Denali stock surges on $150 mln Takeda partnership for up to three neurodegenerative therapies [MarketWatch]
Denali Therapeutics Inc. (DNLI)
Last denali therapeutics inc. earnings: 8/6 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.denalitherapeutics.com
Company Research
Source: MarketWatch
Denali stock surges on $150 mln Takeda partnership for up to three neurodegenerative therapies Denali Therapeutics Inc. DNLI, +3.67% shares surged 3.6% in moderate morning trade Friday on news of the company's $150 million partnership with Takeda Pharmaceutical Co. Ltd. 4502, +0.80% on up to three therapies for neurodegenerative diseases. The agreement also makes Denali eligible for up to $90 million in other payments, and the companies will split global profits equally. Denali will be responsible for development activities and costs, while Takeda will have the option to co-develop and co-commercialize the three therapies, in which case the two companies will work together on clinical development and split costs. Takeda and Denali also plan to jointly commercialize the therapies in the U.S. and China, with Takeda taking on commercial activities exclusively in all other markets. Denali, which is focused on neurodegenerative diseases like Alzheimer's disease, Parkinson's disease a
Show less
Read more
Impact Snapshot
Event Time:
DNLI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNLI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNLI alerts
High impacting Denali Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
DNLI
News
- Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]Yahoo! Finance
- Denali Therapeutics Reports First Quarter 2024 Financial Results and Business HighlightsGlobeNewswire
- Flagship Pioneering Unveils Prologue Medicines to Unlock the Therapeutic Potential of the Viral Proteome [Yahoo! Finance]Yahoo! Finance
- Flagship Pioneering Unveils Prologue Medicines to Unlock the Therapeutic Potential of the Viral ProteomeBusiness Wire
- Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial [Yahoo! Finance]Yahoo! Finance
DNLI
Earnings
- 2/27/24 - Miss
DNLI
Sec Filings
- 5/7/24 - Form 10-Q
- 5/7/24 - Form 8-K
- 4/18/24 - Form ARS
- DNLI's page on the SEC website